Hims, Amazon and Hers

Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.
Amazon service a threat to Hims & Hers’ core offering, says Citi
After Amazon (AMZN) announced its launch of its Amazon One Medical Pay-per-visit telehealth service, which is “very similar” to
Amazon One Medical launches service to compete with Hims & Hers
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five conditions including erectile dysfunction and men’s hair loss.
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%
Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...
Hims & Hers falls -17.7%
Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...
The Globe and Mail6h
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
This might be the case for shares of Hims & Hers Health Inc. (NYSE: HIMS), as the stock is now rallying by over 6% the ...
Yahoo Finance1h
Amazon launches lifestyle drug service as challenge to Hims & Hers
The move into lifestyle treatments is seen as a challenge to companies like Hims & Hers, which saw its stock value drop ...
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, ...
What's Going On With Hims & Hers Health Stock On Wednesday?
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...
Hims & Hers launching GLP-1 tracker, Yahoo Finance reports
In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...